MMP10 and type 1 diabetes mellitus: In the high MMP10 expression subgroup, pathways significantly enriched included those associated with allograft rejection, systemic lupus erythematosus, type I diabetes, mucin-type O-glycan biosynthesis, and graft-versus-host disease (see relevant figures for details).